The Democratic Republic of the Congo (DRC) is currently responding to an outbreak of Bundibugyo ebolavirus (BDBV), a rare species of the Ebola virus that poses significant public health challenges due to the absence of licensed vaccines and specific antiviral therapies.
Unlike previous Ebola outbreaks in the DRC, which were predominantly caused by Zaire ebolavirus and could be managed with approved vaccines and monoclonal antibody therapies, the current Bundibugyo outbreak requires a response focused on early case detection, prompt isolation, high-quality supportive care, stringent infection prevention and control (IPC) measures, and coordinated public health interventions. With cases reported across multiple provinces, the outbreak continues to place considerable strain on the healthcare system, underscoring the need for enhanced surveillance, rapid diagnosis, effective case management, and timely outbreak containment.
To support frontline healthcare workers in their response, here is a quick overview of the ongoing outbreak in the DRC, incorporating the latest recommendations from the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). It covers:
- The current epidemiological situation in the DRC
- The virological characteristics of Bundibugyo ebolavirus
- Routes of transmission
- Clinical signs and symptoms
- Current treatment recommendations and key clinical take-home messages
The snapshot also highlights the critical role of contact tracing, active surveillance, prompt reporting to public health authorities, and strict adherence to IPC protocols in interrupting transmission, reducing mortality, and supporting an effective outbreak response.